Latest / The Thyroid (and Hormone) Fixer Podcast: Thyropause, Menopause, Metabolism and How to Fix It / 336. For All Hypothyroid Patients and Endos: Rethinking Hypothyroidism with Antonio Bianco MD
Transcript
- 0:07Thanks for listening to the Thyroid Fixer podcast with your host, me, Dr. Amy Horniman, AKA the Thyroid Fixer. Also, functional medicine practitioner, hormone and weight loss expert. We're talking all things thyroid, hormone, and health-related in order to empower, educate, and transform you. Remember, I fix your thyroid, I fix your hormones, I fix your life. So let's get started.
- 0:34Dr. Antonio Bianco, thank you so much. It is just an honor to have you on my podcast because actually, well, two things. Number one, I told you this off camera. I have many of your research papers saved. I have that little Mendeley thing that we can save when we're going through a...
- 0:52a doctoral degree, dissertation, master's degree. We get to save these really cool papers. I have so many of yours saved. And I actually recorded a podcast in October of 2020, where I referenced you. And I actually referred him like, he's my favorite researcher because he broke the mold. He talks about T3. So thank you. I am honored to have you as a guest. Thank you very much. It's a pleasure to be with you, Angie.
- 1:18Well, thank you. Thank you. So, you know, I want to dive in. I mean, you wrote a book. I have it right here. Rethinking hypothyroidism. Fantastic book. I love how you wrote it for patients. So it's very understandable for patients. But I would definitely recommend that many doctors read it as well, because you are you're getting into the weeds of
- 1:40the thyroid and where treatment started and how it's evolved. So what, what made you even write this book? What, what are you seeing, I guess, in your research and in, in patients that you felt like this book needs to get out there?
- 1:56Well, I mean, everything started about 10 years ago. And I tell that story in my book when I saw two patients that made me stop and think that perhaps we did not get this completely right. I mean, treatment of hypothyroidism, which I learned in medical school to be such a straightforward and simple thing, perhaps it wasn't that easy and straightforward. And so 10 years ago, these two patients were.
- 2:23made me switch a little bit the focus of my research, which was very basic, very fundamental in the molecules that are involved in thyroid hormone action, to actually address some clinical questions, whether or not we're doing a good job when we treat patients that have hypothyroidism, we just leave a thyrox.
- 2:46So there was a lot of work that was done. Studies were published. I think we found some things. Other people around the world, other scientists also were on the same page, and they were also investigating different things. So I think in the last 10 years, a lot of scientific progress was made in the field of hypothyroidism.
- 3:11And I thought that what was missing was a connection of all of these dots that were old information that was super important and available. However,
- 3:25Because we had this idea that lipoplyroxene resolved everything about hypothyroidism, we sort of stopped looking at other things. So I like to say that research in hypothyroidism was not as fast as it should have been starting around the 70s.
- 3:44And there was a catch up during these last 10 years. And I thought writing a book would make sense because a lot of pieces could be connected in a story that could be both convincing physicians that they have to take a second look at how they treat their hypothyroid patients
- 4:05And also ensuring patients that we are thinking about them and we are listening that perhaps their complaints are not completely, can't be completely disregarded. We need to look at what they're saying and we need to try to address it from a scientific point of view.
- 4:26Absolutely. And do you think that, I mean, you coming from conventional medicine, do you think that we can get through to conventional medicine doctors now? Because, I mean, you've talked about it. I've talked about it on here before. As you know, you learn one thing in medical school. Right. Test TSH, treat with T4, period. Right. Right.
- 4:52Do you think that we can start breaking the mold of that and getting these docs to think outside the box? I think so, because the way we do this is with studies, is with data. We need to get data out there. And I think that, as again, I mean, if you look,
- 5:10very comprehensive studies have been published in hypothyroidism and treatment of hypothyroidism. And just recently, we published a study showing that the number of, if you look at the new patients that were diagnosed with hypothyroidism, how do doctors treat them? The number of patients that the first medicine is treated,
- 5:32Combination therapy has doubled in the last 10 years. Okay. So that is amazing in this country to the point that we have maybe about 2 million patients with hypothyroidism today that are receiving one form or the other of combination therapy. That means includes levothyroxine and T3.
- 5:55Oh, that is, that's absolutely, that gives hope. That gives hope to many. It really does. It's a sign of change. Absolutely. It is. It's definitely a sign of change. So on the role of TSH, you talk about this a lot in your book as well. Why is it that so many rely on just TSH alone? And really, how important is it in testing?
- 6:21Well, TSH, when we talk about TSH, we need to think about two situations. First, in the diagnosis of hypothyroidism. And second, in the follow-up of patients that are being treated for hypothyroidism.
- 6:37In the diagnosis of hypothyroidism, TSH has a dominant role. I know there's great contention between physicians and patients. Patients feel symptoms of hypothyroidism, and TSH is not going up, so you know that in hypothyroid patients, TSH should be higher. So the reflex reaction said TSH doesn't work. So
- 7:01We believe that TSH works in most cases, in the predominant number of cases with hypothyroidism. When does TSH does not work? Well, there's a condition called central hypothyroidism.
- 7:16There are problems in the brain and in the pituitary gland, this gland that controls the thyroid gland. And some individuals have a dysfunction in these glands, pituitary or hypothalamus. And then TSH is really not a good indicator of thyroid function. The number of individuals that have central hypothyroidism is very small. However, when you talk about
- 7:4220 or 30 million patients with hypothyroidism in this country, even a small percentage, let's say we have 5% with central hypothyroidism, it becomes a huge number. So I think we cannot disconsider the possibility that TSH, that central hypothyroidism exists and should be investigated.
- 8:07Now, having said that, there are other things that can mask the utility of TSH. For example, reduced caloric intake. When patients eat low calories, TSH is going to be repressed, is going to be diminished. And then we cannot trust completely the TSH level. I mean, this is something, an information that both doctor and patient need to factor in when looking at their results.
- 8:37There are certain drugs, for example, retinoic acid or steroids, they will also slow down secretion of TSH. So, you know, there's got to be real thinking, real good thought about how to interpret a TSH that is not going up when the symptoms indicate that they could go up.
- 8:59But the vast majority, again, more than 95% of the patients. TSH is a wonderful, phenomenal tool. The problem is when it doesn't work and you have a lot of patients that it could potentially not work, then it becomes a problem.
- 9:15Now, if you look at, is TSH a good marker when we treat patients with hypothyroidism? That's something that I go, you know, and I talk about it in the book. Then I have my question. Then I'm not sure. Then I really question the utility of TSH. Because what happens is when you treat someone with levothyroxine, you can normalize TSH, but the T3 levels are not fully normalized.
- 9:42And this is something we studied in that in my lab. We came up with a mechanism for why that is. So if you're only focusing on TSH, you're forgetting about T3 that could be below the reference range or at the bottom of the reference range. So having a normal TSH doesn't mean the T3 is normalized. That is the key information. And why is this so important? T3 is the active hormone.
- 10:12T3 is the hormone that resolves the symptoms. So if you can't normalize serum T3 levels, T3 in the blood, then, I mean, I think that it becomes a problem, really.
- 10:25I agree. I'm always talking about the importance of T3. And I mean, I've been doing this for seeing patients for about 27 years now. And that is the pattern that I always see is a normal TSH, even a functional optimal TSH, which in functional medicine, we like it below a two. So I'll even have patients come in with a one or a 0.9 TSH. But then you go to the free T3 process.
- 10:50And like you said, it might be a 2.2 or it might just be right over that normal standard lab value or a 2.3. And they're suffering. And I'm really happy that you said that about the caloric intake, because how many patients are so frustrated and they drop their calories and they do the intermittent fasting. And then the TSA, exactly. I mean, I used to receive several referrals from my colleagues
- 11:19not understanding why T3 and T4 were low and TSH wasn't going up. Patients were on a severe caloric restriction to lose weight. And that's what happens. Yep, exactly. Now in the book, you state that the body wants to keep T3 normal, but we don't look at it enough in conventional medicine. Can you explain that whole process of how the body really wants to normalize T3?
- 11:47Right, sure. So this is really amazing. So as you know, most T3 is produced outside of the thyroid gland. The thyroid gland produces some T3, but most of it is produced through those enzymes called the iodineses, right? So that means different tissues, different organs in our body can convert T4 to T3. So that, you know, about 80% of all T3 in the blood comes from outside of the thyroid gland.
- 12:17Now, when you challenge the system that regulates the thyroid gland, and we did this in our lab, creating animals with different genetic mutations, we see that the axis, the system that controls the thyroid, the TSH and TRH, they all change. T4 levels change.
- 12:42However, the only thing that does not change are the T3 levels. So every time we challenge the mechanisms that regulate the thyroid gland, they bend over backwards, change, but the T3 remains stable. So even when we completely eliminate those enzymes that
- 13:06convert T4 to T3, we created a little mouse that lacks the diadenases that convert T4 to T3. You would think, wow, T3 must be very low in those mice. No, not at all. T3 is absolutely normal because the thyroid reacts and defends serum T3 levels. Now, what happens when the patient has
- 13:33lost that ability to defend serum T3 levels. And so serum T3 levels are then regulated by these different tissues in the body that contain the diogenesis. And we've always, I learned that that was not a problem because these diogenesis could adjust and compensate for what the thyroid was producing. As it turns out, they don't.
- 14:02And that's super sad because I have lectured, I have my old slide showing that the iodinease could do this job. And in fact, it's just not true. We have known this since the 70s, 1970s, there are studies showing that
- 14:19the diionases by themselves cannot maintain T3 levels where it should be. As you mentioned, it's either at the very bottom of the normal range or below the normal range. And so that's why in my book, I focus on the idea that when we treat patients with hypothyroidism, we forgot about T3.
- 14:44and we should not forget. We should bring that information back and we need to fix it. Now, where do you like to see free T3 or even total T3 levels in your patients? So I think that we don't have a number. What I think it's the T4 that's slightly elevated, T3 is slightly reduced. I wanna bring this to the normal range again. I think that if we aim at having
- 15:12within the normal range, but in the middle of the normal range. I think that's a good idea. Yeah. Best of all, and I see many patients doing that now, if a patient knows that that patient is going to go through thyroidectomy, so meaning surgical removal of the thyroid gland because of a thyroid nodule or something,
- 15:34We need to make every effort to measure serum T3 before the surgery so we know where it was when the thyroid was healthy. And I think that after treatment, the goal should be, let's bring the T3 back to where it was before the surgery. I think this is such a simple thing, such a simple thing, that it could avoid problems in the future.
- 16:02Well, I think it's absolutely ridiculous to give a thyroidectomy patient T4 only because how can you even possibly normalize them and optimize them when you just remove the thyroid gland that, like you said, it produced a little bit of T3, but it also helped to convert it. So now we're just going to give them T4. Of course, they're going to suffer. I'm sure you saw that a ton as well in your patients. Yeah.
- 16:27Yeah. No. So the problem is, I mean, a little bit of understanding as well. Why did we fall into this trap? Because that strategy that fails to normalize T3, it actually works for a lot of patients.
- 16:45So most patients with hypothyroidism, you and I don't see those patients. They're being seen by primary care physicians, gynecologists, geriatrics. They're millions. If all of these patients were all of a sudden come to the thyroid specialist, we would not be able to see them. So treatment with levothyroxine only works for most patients.
- 17:09However, it doesn't work for a minority. Those are the ones we see. However, a minority, again, of 20 million people is a huge minority. It sounds minority, but we're talking about millions of people. Exactly. So for those ones, leave thyroxine alone, I have my doubts. I think for those, we should do a better job.
- 17:35Now, I heard a stat from A4M, the Academy of Anti-Aging Medicine, and they were stating that only 2% of the population does well on T4 monotherapy, where 98% will benefit from combination therapy. But you say like really it's a small percentage, like 15 to 20% needing T3. Now, are you talking about
- 18:00All of hypothyroid patients. I mean, I really think it's very rare that I see someone doing well on T4 only. Yeah, well, that's very rare. Right. I mean, I think that that's the point. So how many patients are we talking about? Now, depends on who you ask.
- 18:18If you were to come to my clinic, most of my patients are patients for whom levothyroxine didn't work. Because I funnel, I attract these patients because of the kind of work I do. Right. Now, if you go to an office of a primary care physician...
- 18:35that treats a lot of other diseases, you're not going to see a lot of those patients. So we've been talking about what is the number. In my book, I put the number at 10, between 10 and 20%. Now, many patients email me and said it's much more than 20%. Many doctors email me and said it's much less than 10%.
- 19:00So I think we are still, we don't know how many. And I think that that's not,
- 19:08So important. What is important is to acknowledge that they exist because a lot of physicians do not even acknowledge that levothyroxine therapy can fail. And I think that is a big deal, a big deal, because I would like to see more thyroid experts saying levothyroxine is phenomenal. However, for some patients, it does not fully, it's not fully effective.
- 19:36Right. Right. Exactly. So you mentioned the D1 and D2. I want to go down that rabbit hole because I have not yet talked about the diodinase enzymes on my podcast yet, and you're the expert. So let's really break down. I mean, I talk a lot about reverse T3, so I want you to get into how the D1 and D2 help with
- 20:00reverse T3 and D1 clearing the reverse T3. So let's start breaking down those enzymes and their importance. Okay. There are two deiodinases that can activate thyroid hormone. That activate thyroid hormone means transform T4 to T3. There's the type one and the type two. D1 was discovered in the seventies. And for 10 years, everybody thought, well, this is the deiodinase. But then in the eighties,
- 20:30D2 was discovered. And through studies that were done at UCLA and in other places, they discovered that D2 is the key enzyme that produces T3 for the circulation.
- 20:45So 80% of the T3 in the circulation in humans comes from the type 2 diiodinase. So this is a critical enzyme. D1 is not important. Yeah, D1 is important. D1 makes the other 20%. They are regulated differently. D1 is sort of a lazy enzyme when it comes to transformation of T4 to T3. D2 is the active enzyme, is the one that really does a good job.
- 21:13So when we think about a hypothyroid patient that is being treated with levothyroxine, we should think, yeah, D2 is converting a lot of T4 to T3, and that's where the T3 is coming from. Now, you mentioned reverse T3.
- 21:28Reverse T3 is that molecule that loses an atom of iodine in the opposite position of T3. So, and what happens is that reverse T3 is dead. It's not, doesn't do anything. Reverse T3 does not bind to the thyroid hormone receptor. It has no affinity for binding to the thyroid hormone receptor. So,
- 21:53T4 can be converted either to T3 or to reverse T3. If it goes to T3, it's active. If it goes to reverse T3, it's inactive, it's dead. Now, many doctors use levels of reverse T3 in the circulation, and
- 22:12to estimate this alternative pathway. Where is the T4 going? Because the thinking is, okay, we are giving levothyroxine to, I'm giving levothyroxine to my patient, but is the diadenase converting a T4 to T3 or to reverse T3? And I think that that is the idea that let's look at reverse T3. Now, the problem with reverse T3
- 22:41is that when you measure reverse T3 in the circulation, a lot of its levels have to do with the clearance of reverse T3 through D1. D1 is the enzyme that clears. Clears means removes reverse T3 from the circulation. So if you have normal T4 levels and you have a slightly elevated reverse T3,
- 23:06in a patient that is taking levothyroxine, most likely you have a problem with the D1 pathway. We actually identified a couple of years ago two families that had mutations in the gene that encodes the type 1 DINAs. How did we find them? Because everything was normal, but reverse D3 was higher. Yeah.
- 23:29Therefore, I think even though D1 contributes less for T3 production in patients with hypothyroidism, if there's an elevation in reverse T3, it could mean that reverse T3 is not being cleared from the circulation. And that would indicate that T3 production is compromised to the type 1 diadenase pathway.
- 23:53So I know it's a little bit complicated. These enzymes are tricky, but I think we moved because in the past, you would ask people,
- 24:06an academic thyroid specialist, oh, do you measure reverse T3 in the circulation of patients with type of type? Forget about, that's useless. So, and I think that this publication that we had showing that mutations in the type one gene elevates reverse T3, that shows me that that pathway of T3 production has been compromised.
- 24:31Yep. And I have many patients with elevated reverse T3, especially on Levo or high amounts. I'll also see that if a patient is on T4 monotherapy and they just keep getting their dose increased, maybe their doctor gave them a teeny tiny amount of T3 of lyothyronine, like 5, 10 micrograms. But that amount of T4 is just so overpowering.
- 24:58They convert it to reverse and I'll see that elevator reverse. And that's the issue right there. And then you lower the T4 dose, increase the T3 dose. The reverse comes down. The patient feels better. Right. I mean, I think you're right on the spot.
- 25:14when you say the levels of reverse T3 depend on the levels of T4. Yes, that's absolutely right. When you look at reverse T3, you always should look at the T4, because if you have a high T4, that's exactly, reverse T3 comes from T4. But if you keep building up T4, reverse T3 is going to go up as well. So we should always look at both at the same time.
- 25:38And I heard you say, and I actually, again, use this as a quote in one of the talks that I've given, that endocrinologists know that if you give T4 and you keep building up that dose, it's going to drop the T3 levels. And it's fascinating because it's like they know it and they still do it because they don't place the importance on T3 like they should.
- 26:03Yeah, we have shown this very recently. I would not say that this is a widespread thing because we are still, I published a couple of papers on it. I showed recently a paper in which T4 can go up, up and up. T3 absolutely does not change at all.
- 26:24And there are situations that you're right. The more T4 you give, you kill the enzyme that makes T3. It's a self-regulatory mechanism. And you can kill T3, which is, can you imagine? If you give a lot of T4, you can kill T3 production. I don't think we were prepared for that information, but in certain parts of the body, that's certainly true. Yeah.
- 26:52So I'm going to go back to the D1, D2, and I'm going to throw out myself as an example so we can kind of unpack that. I've never tested my genetics to see if I have a SNP of the D1, D2, but I am T3 only. And if you give me T4 at all,
- 27:12You won't see my reverse climb as quickly as my symptoms do. So you could give me 25 micrograms of Levo and I will be 10 pounds heavier in a week. I will be clinically depressed. I will have no motivation whatsoever. My energy will be in the toilet that quickly. And I know because I've experimented on myself. Yeah.
- 27:32So, I mean, would you say without even testing me, I probably have some kind of mutation in my, what would it be, the D2 pathway? I don't think I can say that. What I can tell you is this. Ten years ago, when I started looking at this carefully, when a patient came to my office and said, I take only T3. And I think I even talk about these patients in my book.
- 28:02I would just say, you're absolutely nuts. You're doing something wrong. This is wrong. You need to take T4. And I would try to convince and try. And the patients, most of them were very nice and said, yeah, let's try this, try that. I never was able to do it because those patients only felt good taking T3. Now, as I...
- 28:29progressed in this journey of understanding more about the treatment of hypothyroidism, I saw that there are many patients that only do well on T3. And I had to learn this from my patients, not from any book or any meeting, conference, nothing, because this is, you know, you don't talk about that. Right. If you're only T3, you don't go to a conference and talk about that. So I learned that from my patients.
- 28:56Now, what I know today is, what you described is absolutely right. Some patients can only function well taking T3 monotherapy. Why that is, I don't know. I think that we still need to understand that. I do not believe at least the SNPs that we know could explain this.
- 29:19Could SNIP explain this? Yeah, it could, but we don't know anyone that could. We're still trying to understand. The problem is this is such a taboo topic
- 29:30that we would need to get doctors to get a group of patients that only function on T3 blindly. We would need to do a blinded study in which the doctor doesn't know what's prescribing, the patient doesn't know what's receiving, and we would need to address that. But I don't see anyone doing that in the near future. Maybe they will, but I don't know the mechanism to explain why you feel the way you feel.
- 30:01And that'd be a hard sell too, because those of us who are T3 only, no way in hell are you going to give us T4 because we know how we're going to feel. As part of the study, I mean, I think that you volunteer to understand this better. As part of the study, you have a 50-50 chance to be randomized to T3 only or to T4.
- 30:23You do. It would be interesting. Yeah, it would be an interesting study, I have to say, because I bet you patients will know right away once they switched. At least that was my experience with my few patients I had on T3 only. They do not tolerate levothyroxine.
- 30:43And it is very rare. I will say that. I'll say that for the audience too. It is very rare. I mean, if we were talking percents, I would say maybe, you know, one out of every, maybe 200, 500 need T3 only. But when they do, they do. You know, when a person is truly T3 only and maybe the reverse T3 escalates quickly, it goes up very quickly with a small amount of T4, or maybe it doesn't.
- 31:08Right. Maybe symptoms come on first and those become that's how it is for me. Those become so debilitating. Now, with T3 only or even let's even talk about when we when we do the combination therapy, I try to explain to patients, listen, your TSH is going to go down and it's probably going to become suppressed to the point where a conventional doctor will look at it and call you hyper. Yeah.
- 31:34So what is your take on that TSH then going down once we start adding in some T3? For combination therapy. Right. So you said a couple of things very important. If we want to start someone on combination therapy, at least that's how I do it and how it's accepted by the professional academic societies. You have to remove a little bit of the dose of,
- 32:03Lower the dose of levothyroxine so you make space so that you can start prescribing the light iron, the T3. So if you do that, you're not going to suppress the TSH. You have to really keep in mind that there are lots of things to juggle here. First is the patient needs to feel better. Second is you want to bring T3 and T4 levels to the normal range.
- 32:33Third is you want to keep the TSH at least detectable. Having a TSH suppressed is not good. How do we know that? Because there are studies, and these studies are important.
- 32:47not controverted. They are very straightforward. There are studies with lots of patients showing that if you carry a suppressed TSH for a long time, you increase your risk of atrial fibrillation and you increase your risk of bone fractures. Now, having said that, again,
- 33:08We're not computers, right? Because if you talk to a computer, if you present a problem, the computer will always give you the same answer, right? There's a balance between risks and benefits. I have had patients on a wheelchair that would not come out of the wheelchair without having a suppressed TSH. Now, the patient is coming from out of state
- 33:38Just because in the area she lived, doctors will not accept suppressing a TSH. Right. She was taking antidepressants, was following up with a psychiatrist. So what do we do in this case? Do we suppress TSH? Do we allow suppressing the TSH with a slightly elevated dose of thyroid hormone?
- 34:03taking a risk, an increased risk, at the same time that the benefit is tremendous for that patient. So for me, that's why physicians and doctors need to talk about these things and say, well, this is our collective decision here. If you are willing to take this increased risk for a better quality of life, then...
- 34:28And also the judgment of the physician should be playing a role as well. In the cases I had, which were a handful, I think I had no doubt that having a suppressed TSH was beneficial for those patients, all things considered. Right. Just think about it. Patients that have thyroid cancer, how are they treated? Right.
- 34:54we suppress serum TSH for years, for years and years. So why we accept the increased risk of having a suppressed TSH? Because the benefit is making sure we don't have a recurrence of the cancer. I mean, we just have to not emotionally, but analyze these things in a rational way. And it does make sense.
- 35:20Well, it comes down to that personalized medicine, right? If you look at each individual and let's take me, for example, of course, I have a suppressed TSH because I've been T3 only for almost 20 years. So I take care of myself. I do weight bearing exercises. I take magnesium, vitamin D with K. My bones are fine. I just had a DEXA scan last April. Everything's amazing. Okay.
- 35:44Right. And my heart, I've had EKGs. Perfect. Fine. So it has to be each individual. Now, you might take an out of shape 60 year old woman who doesn't weight train and doesn't take supplements and doesn't take care of herself and eats processed foods and has a high insulin level and has all kinds of metabolic disease.
- 36:04Yeah, she's going to be more at risk for bone fracture. So she has more risk factors. More risk factors, exactly. So, I mean, that's why the doctor exists. The problem is that, you know, we need to look at the whole picture. Personalized medicine requires time.
- 36:23with the doctor. That's it. Right. We go see a doctor these days. You take, you have 20 minutes because the doctor already has another patient, another patient, another patient. So it's, it's the hope of the whole system is not working for patients that require more time, more attention, more, you know, a more intense follow-up just because the physicians and I, and I recommend,
- 36:52When patients email me and ask, first ask a doc, find a doctor that will have time to talk to you. Because if you go to a doctor that is looking on the watch for the next patient, that's not going to be good. Right.
- 37:10Right. And that's really what insurance allows, right? That five to seven minute visit is all you get nowadays. Well, five and seven, I mean, I don't know. I mean, I know about 20 minutes. Five to seven. Yeah, maybe, maybe, you know.
- 37:24I jokingly say that, but maybe, yeah, maybe you'll get 10 to 20. Maybe you'll get 10 to 20. But even 20 minutes is not a lot. It's not a lot. It's very, very little. Right. Absolutely. Now, I also, I appreciate the fact in your book that you go outside of the thyroid too. And you do mention, listen, we do have to look at...
- 37:46perimenopause, menopausal symptoms, iodine deficiency, all the other conditions that can occur, insulin resistance, that can mimic the same symptoms or exacerbate. Right, exactly. I think that's really important. And I have to say, when a patient comes and says, and I make the diagnosis of residual symptoms of hyperfiburidism,
- 38:10Before we make the diagnosis, we need to exclude other conditions because the symptoms are not unique to hypothyroidism. What are the symptoms? Low energy. I feel tired. I'm gaining. I have difficulty managing my body weight. I feel forgetful. I'm very sleepy. My hair is falling. My skin is dry. Well, these are symptoms of perimenopausal. I mean, you can't distinguish them.
- 38:40Therefore, vitamin B can cause that, anemia, iron deficiency, as you mentioned, diabetes, obesity. So before we say, oh, yeah, levothyroxine didn't work, let's start with T3, we need to do a thorough investigation and say, well, first of all, let's look at other conditions that could cause this. And, you know, I recently published.
- 39:05published a study, and there are others as well, showing like a pathway. What are the steps that the physician should take before concluding that levothyroxine has failed? What are the tests that we should ask and how to interpret those tests and what to do if the test comes back normal? It is talking with my colleagues and my experience about,
- 39:29I would think that perhaps as much as half of the patients that come with residual symptoms, you end up finding something else that's not the thyroid. And you fix that and patient will feel better. Now, it is true that will be a lot of patients that you cannot find anything. And for those, it's not me that I'm saying, the American, the British, the European Thyroid Association, for those patients, you could not find anything.
- 39:59we should try a combination therapy. And then don't you also find too, it's almost like the reverse. So not only can insulin resistance be there and contributing to the weight gain and the lethargy, but also with the thyroid being off, that can start to dysregulate insulin since that's a hormone. So it's almost like a back and forth play where...
- 40:23In my opinion, you have to do both. You have to start treatment with the thyroid and do that properly, but also at the same time address the insulin resistance. So they're not feeding each other.
- 40:34Yeah, well, what you're saying makes perfect sense. And however, we don't have a clinical trial. We don't have a study showing that hypothyroidism leads to the metabolic syndrome, for example. Let me get back here. Yeah. Hypothyroidism can do that. Not that patients treated with levothyroxine are easier to develop metabolic syndrome. That we don't have that study. As far as we're concerned,
- 41:04When you treat someone with levothyroxine, we have elevated cholesterol. Even though TSH is normal, cholesterol always remains elevated. You have lower energy expenditure. Therefore, you have a tendency to gain weight. But you do not have increased insulin resistance levels.
- 41:25At least we haven't demonstrated. I mean, I wish I had the tools right now to demonstrate. In the back of my mind, I think that's true, but it hasn't been done. So, and I have, as a rule, I only say things that I know that was a clinical trial showing, but it makes a lot of sense.
- 41:46Yeah, but there's that correlation there. Now, you mentioned, well, I mentioned iodine. I know you mentioned it earlier in our talk. How important is sufficient iodine in the treatment paradigm, whether you're doing T4 monotherapy or combination therapy? Well, the iodine is the building block of the thyroid hormone. So when the thyroid gland is working, you need iodine.
- 42:12If you don't have iodine, the thyroid will not be able to produce sufficient amounts of T4 and T3. How much do we need? About 150 micrograms of iodine per day. That's the bare minimum. We know that, for example, in this country, most people are okay in the intake of iodine. However, certain populations are at risk of having iodine deficiency.
- 42:42Who are they? Pregnancy, for example. Pregnant women have an increase in the requirement of iodine. So if they're eating 150 and now they need 250 or 300,
- 42:57then they're going to be at risk for iodine deficiency. And that's a problem, big problem for the fetus that's developing. So iodine supplementation is actually mandatory. I mean, it should have been mandatory. I don't think it's mandatory, but it should be mandatory for ladies that become pregnant. Now, once the patient has hypothyroidism,
- 43:24the thyroid doesn't work anymore, then the iodine loses its role because the thyroid is not making any more thyroid hormone. You know what I mean? So then I would not focus so much of iodine intake for those individuals that have hypothyroidism, but I would focus on especially children and pregnant women. Those are very important to have a healthy intake of iodine.
- 43:52Definitely. And what about Hashimoto's? Because I know that that's, I mean, iodine in and of itself is very controversial in our world of hypothyroidism in general. But what about with Hashimoto's? I mean, I really think you can get a 50-50 split if you poll doctors where 50% will say, nope, it's going to send you into a thyroid storm. You're going to become hyper.
- 44:12And then the other 50 say, well, you know what? I mean, your thyroid gland is being destroyed slowly by your immune system, but that iodine might come in and support the immune system. It might help regulate underlying infections and viruses and just help support that T4 to T3 conversion. Okay. So...
- 44:31Hashimoto's, what you're talking is a patient that has TPO antibodies positive, but still has a thyroid gland that's functional. So we're calling that patient Hashimoto's, but not necessarily with the overt hypothyroidism. So
- 44:48I understand. So there is a risk that if you start giving iodine, depends on the amount, right? If you're giving 100 micrograms per day, I doubted that you're going to trigger thyroid toxicosis, iodine-induced thyroid toxicosis. However, if you give large amounts of iodine,
- 45:08There is a possibility. It's not for sure that you're going to do that, but there is a possibility. If you have a silent autonomous nodule there that requires iodine to go crazy, and if you give a lot of iodine, you can have that. How do we know that? Sometimes it happens in patients that take iodinated contrast for radiographic contrasts.
- 45:34Patients that take adeniodarone, for example, can have that, which is an antiarrhythmic that contains a lot of iodine. So that can happen.
- 45:44Now, what I heard is that selenium has a role for patients that have Hashimoto's due to its antioxidant role. I don't have any experience. This is not recommended by any professional guidelines. However, there are some publications showing that if you give selenium to a patient with
- 46:08TPO positive antibodies, you can actually reduce the title of the TPO antibodies. And yes, same with black cumin seed oil. There's been a lot of studies with black cumin seed and reducing TPO antibodies in place of using something like low-dose naltrexone. So since we're talking about it, what is your opinion on using LDN? Do you ever use that with your patients? No. Not really? No, I don't. Yeah. What I have seen
- 46:36is, which again is not recommended by any guidelines, but I have received patients that were trying to become pregnant. Sometimes they were doing IVF and the doctor that was taking care of that patient was concerned about positive TPO antibodies. So they would be treated with steroids.
- 46:59And in the beginning, when I first saw a patient, I said, well, this is crazy. I never heard about this because, again, it's not in the clinical guidelines. It's not in any books. But you learn about it because the patients tell you. Right.
- 47:13And then I saw many patients in which this happened. I asked my colleagues who specialized on reproduction and hypothyroidism, and they said, well, I've seen as well. The reality is the utilization of steroids in those situations.
- 47:31reduce the title of the TPO antibodies dramatically. So it works. Now, if that helps with the pregnancy, I don't know. I mean, I believe the doctors believe that it helps. So, but I have not seen a publication yet that maybe someone is working on this right now.
- 47:54Right, right. That's interesting. I haven't heard of that either. So that'll be interesting to see if anyone comes out with that. Yeah. I had patients, a few patients with that story. Okay. Interesting. Yeah. Just something else to start looking into to help patients. And actually, that's my next question for you. I want you to touch on before you go, the intermittent fasting thing. I heard you mention that that's not always good and that that can actually push down our
- 48:21are T3 levels and so many people are doing it. So I try to tell these ladies, ladies, especially because that's who gets hit the hardest with thyroid issues. Please do not intermittent fast trying to lose weight because you could actually be making your situation worse. Do you agree? I don't have information about intermittent fasting. What I have is
- 48:44reduced caloric intake. Okay, fasting, fasting. Like true, yeah. Well, I mean, it doesn't have to be fast. If you stop eating in 24 hours, your T3 is going to be lower. That's for sure.
- 48:57But people that are taking up about 800 calories per day, 750 calories per day, that's very low amount of calories. Some people take less than that. Those individuals will have a tendency to drop T3 in the circulation. This is probably not a good idea if you're trying to lose, to accelerate your metabolism. You see what I mean? So...
- 49:24This is a protection mechanism that the body has. If you're not eating, you slow down your energy expenditure because there's got to be something wrong. Maybe you're from an evolutionary point of view. You want to preserve food in your body. If you're not eating, you stop, you reduce the speed at which you're losing calories. So does it happen when you do intermittent fasting? No.
- 49:51Maybe we have to have a study. We will need to do a study to find out. I don't know.
- 49:56Well, wouldn't that also push up reverse T3? Because since reverse goes up in any kind of trauma type of situation, if the body perceives that it's in a starvation mode, wouldn't that increase the reverse T3 as well? Reverse T3 will be up. Yeah. But because of what you said, but most importantly, because the enzyme that's very sensitive to fasting is D1. And D1 clears reverse T3, as we discussed. Right.
- 50:25So when you do it fasting, the first enzyme that's going to go down is D1. And that's when the reverse T3 goes up. So it's really an automatic thing. And you can monitor reverse T3 because that's going to show up.
- 50:44Well, now this is interesting because I'm going to start looking at this a little bit differently when I'm looking at patients' labs. Oftentimes, you know, we talk about the optimal value for reverse T3. In my role, that's less than a 12%.
- 50:59I'll accept less than 15 if they're asymptomatic and the free T3 looks good and they're feeling good and all that, then we just leave it alone. But I think too many, in talking about the functional labs, many people, my listeners alike will get locked in on what that number has to be. And they don't realize that maybe that number is elevated because you decided to do a three day water fast, or you decided to do...
- 51:2718 to 20 hours of fasting every single day and eat one meal a day. So it has nothing to do with your thyroid medication and everything to do with what you're choosing to do to your body. I would agree with you. The thyroid is incredibly sensitive to caloric intake, to caloric manipulation.
- 51:47And the thyroid goes to sleep when you don't eat a lot of calories. And then it wakes up and starts to function. The more calories you eat, the more the thyroid will work out. But then when you stop eating and you reverse, it's going to go back. So I think the situations you described could very well be affecting the thyroid function, which is...
- 52:15not ideal, I guess. Right. That's, yeah, I'm happy you said that too, because again, we have to look at the whole picture. We have to look at what we're doing as thyroid patients to our own bodies in trying to reduce symptoms. And sometimes those aren't the best choices and they're choices that could actually make the situation worse. So I'm really happy that you said that. We need more studies. I think that this is all fascinating. We need more studies on this.
- 52:41We do. We absolutely do. Well, Dr. Bianco, thank you. I mean, just having you on has been just such a pleasure, such an honor. You've delivered so much great info for my audience. I know they're going to eat this up. So if you wanted to, do you want to leave anyone with any message or just simply get the book and read it? That's what I'm going to say, because we're going to put this in the show notes too, with a link to how to get it.
- 53:05Well, first of all, read the book. Yeah, read the book. But second, I think we're going through a very exciting time, a time in which we woke up from that idea that hypothyroidism was a resolved situation, a very simple disease. I learned that in my first year of medical school, this is the easiest disease to treat. And so we spent decades thinking like that.
- 53:32And I believe in the last 10 years, we changed gears, we changed lanes, and we're trying to catch up. So there's a lot of hope and excitement. And I think the patients should be hopeful and should also look for doctors that have a little bit more of an open mind.
- 53:51I think that we all practice different types of medicine. If a doctor says, I'm going to give you levothyroxine and that's it, okay. I mean, instead of butting heads, you just go find another doctor. Because the number of doctors that are more accepting of this idea that we still need to learn more about our hypothyroidism has increased a lot.
- 54:22And you are helping to change their minds. So I thank you for that. I thank you for that. So thank you once again for your time. I greatly appreciate it. It was my pleasure. Thank you very much for having me. Absolutely.